Clearwater Paper Corp. 2024 Annual Report (10-K) Summary
Business Context and Reporting Period
This Form 10-K covers the fiscal year ended December 31, 2024. Clearwater Paper Corporation is a premier manufacturer of Solid Bleached Sulfate (SBS) paperboard packaging products. In 2024, the company executed a strategic transformation to focus solely on the paperboard industry. This involved the acquisition of a paperboard manufacturing facility in Augusta, Georgia (May 2024) and the divestiture of its Consumer Products (tissue) division (November 2024). The tissue business is now reported as discontinued operations.
Key Financial Metrics
| Metric | 2024 | 2023 | Change |
|---|---|---|---|
| Net Sales (Continuing Ops) | $1,383.6 million | $1,136.0 million | +21.8% |
| Gross Profit | $76.1 million | $200.7 million | -62.1% |
| Income (Loss) from Continuing Ops | ($64.5) million | $78.1 million | -182.6% |
| Net Income (Total) | $196.3 million | $107.7 million | +82.3% |
| Adjusted EBITDA (Continuing Ops) | $36.0 million | $122.0 million | -70.5% |
| Cash from Operating Activities | $61.4 million | $190.7 million | -67.8% |
| Total Debt (Long-term + Current) | $284.1 million | $445.0 million | -36.2% |
| Cash and Cash Equivalents | $79.6 million | $42.0 million | +89.5% |
Note: Net Income for 2024 includes a $307.2 million gain on the sale of the tissue business. Income from continuing operations reflects a loss due to market conditions and integration costs.
Material Changes vs. Prior Period
- Revenue Growth: Net sales from continuing operations increased 21.8% primarily due to the inclusion of the Augusta facility. However, this was offset by a 12.0% decrease in paperboard sales prices and a 27.7% drop in pulp shipments.
- Margin Compression: Gross profit declined 62.1% year-over-year. This was driven by announced price decreases, higher costs from planned maintenance outages at Lewiston and Augusta, and increased labor/overhead from the new acquisition.
- Cost Structure: Cost of sales rose 39.8% due to the Augusta acquisition. Input costs (raw materials/energy) increased 24.4% in total dollars, though per-ton costs decreased due to deflation.
- Debt Reduction: The company utilized proceeds from the tissue divestiture to repay $931.1 million in long-term debt, significantly reducing total indebtedness.
- Discontinued Operations: The sale of the tissue business generated a pre-tax gain of $307.2 million, which was the primary driver of the positive Net Income for the year despite the loss in continuing operations.
Guidance, Outlook, and Risks
Outlook: Management expects continued improvement in demand for SBS paperboard in 2025, anticipating a return to pre-COVID levels by year-end. However, this is expected to be offset by new market capacity coming online in Q2 2025. The company views the current market as a temporary downcycle.
Cost Reduction: The company is targeting $30 million to $40 million in cost savings in 2025 across operations and SG&A. This includes restructuring initiatives with expected severance costs of $5.0 million to $7.0 million.
Capital Expenditures: Expected to be approximately $80 million to $90 million in 2025.
Key Risks:
- Integration Risk: Challenges in integrating the Augusta facility could delay expected benefits.
- Market Conditions: Cyclical industry conditions, customer destocking, and increased competition from foreign and domestic manufacturers.
- Input Costs: Volatility in wood fiber, energy, and chemical prices.
- Debt Covenants: While currently compliant, a decline in availability under the ABL Credit Agreement could trigger fixed charge coverage ratio tests.
- Multiemployer Pension Plans: Potential withdrawal liabilities if the company exits underfunded plans (estimated exposure exceeds $75 million if withdrawn immediately).
Investor Verification Checklist
- Continuing Operations Viability: Verify the trajectory of Adjusted EBITDA from continuing operations, which dropped to $36.0 million, excluding the one-time gain from the tissue sale.
- Augusta Integration: Monitor the realization of synergies and cost savings from the $708 million Augusta acquisition.
- Debt Covenant Compliance: Track the Fixed Charge Coverage Ratio and ABL availability to ensure no covenant triggers are breached in a downturn.
- 2025 Cost Savings: Confirm the execution of the targeted $30-$40 million in cost reductions and the associated restructuring charges.
- Pension Exposure: Review the status of the PIUMPF and IAM NPF multiemployer plans and any potential withdrawal liability assessments.